The renin-angiotensin system and experimental heart failure.
about
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseMechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expressionSirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activityAngiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failureMicrotubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative diseaseIncreased renal ENaC subunits and sodium retention in rats with chronic heart failure.Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.The ACE gene and human performance: 12 years on.Influence of aerobic training on the reduced vasoconstriction to angiotensin II in rats exposed to intrauterine growth restriction: possible role of oxidative stress and AT2 receptor of angiotensin IIDexamethasone and cardiac potassium currents in the diabetic ratFirst-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination.Renal hemodynamic and morphological changes after 7 and 28 days of leptin treatment: the participation of angiotensin II via the AT1 receptor.Abnormal baroreflex function is dissociated from central angiotensin II receptor expression in chronic heart failure.Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies.Cardiac GPCRs: GPCR signaling in healthy and failing hearts.Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.High-salt diet during pregnancy and angiotensin-related cardiac changes.Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinasesA critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.Designing heart performance by gene transfer.Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.Unfolded protein response regulates cardiac sodium current in systolic human heart failureParicalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats.Boerhaavia diffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-κβ and transforming growth factor β1.Three-dimensional alignment of the aggregated myocytes in the normal and hypertrophic murine heart.New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats.Differential autocrine modulation of atrial and ventricular potassium currents and of oxidative stress in diabetic rats.Alterations of cardiac ERK1/2 expression and activity due to volume overload were attenuated by the blockade of RAS.The mechanism of distinct diurnal variations of renin-angiotensin system in aorta and heart of spontaneously hypertensive rats.Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failure.Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes.Attenuation of changes in G(i)-proteins and adenylyl cyclase in heart failure by an ACE inhibitor, imidapril.Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.Cardiac structure and function in a mouse model of uraemia without hypertension.
P2860
Q26772221-87A7FFD3-64CE-4AEA-8B2F-FB772B352198Q28077454-EEF3612B-C427-4410-847D-C27A7221B638Q28567598-68CAB154-B3E0-4C65-8282-190E7FE344ACQ28568033-80B629A1-8EC5-4589-A761-DB1B65A7EA94Q28573667-51FDC51E-477D-44F5-85DE-49A3BC00CD79Q28591529-F77A54A8-A147-4550-B174-86A144A4EEFFQ33796947-FA8A71AB-4A4C-4A4D-A72B-C92CB866DCD3Q33902466-9E9987C2-7496-4AF3-88C2-A0CA2476E81EQ34187481-3683F349-B65A-4D0F-B02F-29B23E1D256AQ34535904-DFF4C36C-CF2E-4C7D-8A07-EF9649E0D021Q35049161-D99FE311-5F88-4A5E-B7BC-7A46D117762DQ35210508-D2BBCD92-63B5-4932-9236-ACCAD147F2CFQ35582167-D7DC2334-41CC-46AF-B179-BA43BADB7615Q35761928-D7BC5F05-9D7F-4AF3-A8D1-0B77B7533B35Q35828486-9FC3710D-7695-4A27-A597-6357A8E43A5AQ35842857-C70EAB00-708F-4501-A745-FBDC8096C834Q36216855-2C3A1B36-554E-4D2B-84D6-636FC6400FD2Q36678081-5DA59538-5194-4005-B931-31034FF23C7BQ36816747-7E3E30D7-B943-4A68-B148-EC3ABE19A044Q37103505-A1436CA1-BEFA-4FB2-B18A-4DC78796CDB8Q37182864-24BB5885-3079-4980-B22A-DA984002BB67Q37299072-660748AC-1F22-401E-BE3A-DF9998B7D7EEQ37397232-01FB0C24-2C45-4987-9309-00C76420D0ADQ37520430-5C690E1D-8819-411D-9F27-F396FB80373DQ37540104-4A900C90-8E23-488F-80E8-E2F95E98B93FQ37690771-ACF1460A-55EE-4AEC-8B83-D862CC922F45Q37693557-BBAAF48E-33B2-4C71-9457-F88179D9AD73Q39165397-EF5A4181-96F4-4977-B3EB-002D3CEF9337Q42457455-A563E1F9-59CD-44D8-8002-51B16B0E0749Q42463523-2EBECD89-2BCE-400B-BDD9-22D236BB55CAQ42487712-8299ECFC-B994-46EE-A2E2-1805E904ACECQ43184378-D3110EA1-BE53-4C53-9C99-4C94EFF7990EQ43225779-B23E5696-D37F-4C7A-8B6A-182459286C8CQ43617419-346C34AA-F6E5-4C30-A756-794D4123DA52Q43926591-62B7744F-AF08-4B4E-8810-BB7E3EC0A1EDQ44355553-96C46A92-1C32-4143-AF26-55C442602B87Q44640247-51BDB9E5-F060-4B01-AC23-3A350478F9F8Q44654247-A430509C-D800-4BF9-A50E-95C837BF9BF5Q44776902-23644CC8-5229-4BF0-81C7-D1DA7E3E03EAQ46044948-CE2BD039-D97F-4B7D-BA13-2BC6521335E2
P2860
The renin-angiotensin system and experimental heart failure.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The renin-angiotensin system and experimental heart failure.
@ast
The renin-angiotensin system and experimental heart failure.
@en
type
label
The renin-angiotensin system and experimental heart failure.
@ast
The renin-angiotensin system and experimental heart failure.
@en
prefLabel
The renin-angiotensin system and experimental heart failure.
@ast
The renin-angiotensin system and experimental heart failure.
@en
P1476
The renin-angiotensin system and experimental heart failure.
@en
P2093
P304
P356
10.1016/S0008-6363(99)00145-5
P577
1999-09-01T00:00:00Z